The information on this site is provided by CodeMap®. CodeMap® remains solely responsible for its content. The information provided is for general educational purposes only and may not be conclusive or exhaustive. Recent changes in applicable law, regulations and interpretations may not be reflected in the information contained herein. For technical questions, please contact Dr. Charles Root.

This website is a private website and is not associated, endorsed or authorized by the Department of Health and Human Services, the Center for Medicare and Medicaid Services or any other public or government organization or agency.

CodeMap®-BD MAX™ System Reimbursement Information

Please select your state/locality before continuing:

Fees Reflect 2017 CMS Medicare Fee Schedules

While sequestration is in effect, all CMS payments for services will be reduced by 2%.
The fees below do not reflect this reduction. Click here for more information.

BD MAX™ SYSTEM

Redefine staff productivity with a fully-integrated, automated molecular platform capable of running both IVD and open system assays efficiently and flexibly.
BD MAX™ Enteric Panels
CPT® Code Description
Medicare Coverage
NATIONAL LIMIT
Medicare Reimbursement
Enteric Bacterial Panel:
Includes 4 targets: Salmonella spp., Campylobacter spp. (jejuni / coli), Shigella spp, and Shiga-toxin producing E. coli (STEC)
  87505 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets
  CCI  
$175.98
BD MAX™ Extended Enteric Bacterial Panel:
Incudes 4 targets: Vibrio (vulnuficus / parahaemolyticus / cholerae), Yersinia enterocolitica, Plesiomonas shigelloides, and Enterotoxigenic E. coli (ETEC)
  87505 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets
  CCI  
$175.98
BD MAX™ Enteric Parasite Panel:
Includes 3 targets: Giardia lamblia, Cryptosporidium (parvum / hominis), and Entamoeba histolytica

  87505 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets
  CCI  
$175.98



BD MAX™ Enteric Panel Combinations
CPT® Code Description
Medicare Coverage
NATIONAL LIMIT
Medicare Reimbursement
Enteric Bacterial Panel and Extended Enteric Bacterial Panel:
Includes total of 8 targets: Salmonella spp., Campylobacter spp. (jejuni / coli), Shigella spp, and Shiga-toxin producing E. coli (STEC), Vibrio (vulnuficus / parahaemolyticus / cholerae), Yersinia enterocolitica, Plesiomonas shigelloides, and Enterotoxigenic E. coli (ETEC)
  87506 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 6-11 targets
  CCI  
$292.77
Enteric Bacterial Panel, Extended Enteric Bacterial Panel and Parasite Panel:
Includes total of 11 targets: Enteric Bacterial Panel and Extended Enteric Bacterial Panel:
Includes total of 8 targets: Salmonella spp., Campylobacter spp. (jejuni / coli), Shigella spp, and Shiga-toxin producing E. coli (STEC), Vibrio (vulnuficus / parahaemolyticus / cholerae), Yersinia enterocolitica, Plesiomonas shigelloides, and Enterotoxigenic E. coli (ETEC), Giardia lamblia, Cryptosporidium (parvum / hominis), and Entamoeba histolytica
  87506 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg, Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 6-11 targets
  CCI  
$292.77



BD MAX™ Individual Assays
CPT® Code Description
Medicare Coverage
NATIONAL LIMIT
Medicare Reimbursement
BD MAX™ Cdiff Assay
Clostridium difficile toxin B gene (tcdB) in human liquid or soft stool specimens.
  87493 Infectious agent detection by nucleic acid (DNA or RNA); Clostridium difficile, toxin gene(s), amplified probe technique
  CCI  
$48.14

BD MAX™ MRSA XT Assay
Rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) DNA from nasal swabs.
  87641 Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, methicillin resistant, amplified probe technique
  CCI  
$48.14
BD MAX™ GBS
Group B Streptococcus (GBS) DNA in Lim broth cultures obtained from vaginal-rectal swab specimens from antepartum pregnant women.
  87150 Culture, typing; identification by nucleic acid (DNA or RNA) probe, amplified probe technique, per culture or isolate, each organism probed
  CCI  
$48.14

BD MAX™ CT/GC/TV
Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis.
  87491 Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique
  CCI  
$48.14 (Individual test)
  87591 Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique
  CCI  
$48.14 (Individual test)
  87661 Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, amplified probe technique
  CCI  
$48.14 (Individual test)
Total Medicare Reimbursement:
$144.42
BD MAX™ StaphSR
Direct detection and differentiation of Staphylococcus aureus (SA) and MRSA DNA from nasal swabs.
  87640 Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, amplified probe technique
  CCI  
$48.14 (Individual test)
  87641 Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, methicillin resistant, amplified probe technique
  CCI  
$48.14 (Individual test)
Total Medicare Reimbursement:
$96.28



BD MAX™ Vaginal Panel

Includes:
CPT® Code Description
Medicare Coverage
NATIONAL LIMIT
Medicare Reimbursement
Single result for 5 vaginosis markers (Lactobacillus spp. (L. crispatus and L. jensenii), Gardnerella vaginalis, Atopobium vaginae, Bacterial Vaginosis Associated Bacteria-2 (BVAB-2), Megasphaera-1)
  87801 Infectious agent detection by nucleic acid (DNA or RNA), multiple organisms; amplified probe(s) technique
  CCI  
$96.29 (Individual test)
Single result for Candida species. (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis)
  87481 Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe technique
  CCI  
$48.14 (Individual test)
Candida glabrata
  87481-59 Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe technique
  CCI  
$48.14 (Individual test)
Candida krusei
  87481-59 Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe technique
  CCI  
$48.14 (Individual test)
Trichomonas vaginalis
  87661 Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, amplified probe technique
  CCI  
$48.14 (Individual test)
Total Medicare Reimbursement for Panel:
$288.85



Becton, Dickinson and Company is not responsible for any actions taken by website users in billing Medicare for Becton, Dickinson and Company products, equipment or devices, including but not limited to, any billing and/or coding errors. Website users rely on the information contained in this website at their own risk and should check with the individual Medicare contractors to verify coverage, coding and payment.

The information contained in this website has been compiled by CodeMap, L.L.C. to assist Becton, Dickinson and Company customers. CodeMap, L.L.C. remains solely responsible for its content. The information provided is for general educational purposes only and may not be conclusive or exhaustive. Recent changes in applicable law, regulations and interpretations may not be reflected in the information contained herein. For technical questions, please contact Dr. Charles Root at (847) 381-5465.

CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this website. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.

No part of this web page or data displayed may be redistributed or used without the express written consent of CodeMap®.

10/21/2017 07:38:49 54.80.148.252